BR100 Increased By (1.02%)
BR30 Increased By (1.71%)
KSE100 Increased By (0.58%)
KSE30 Increased By (0.65%)
BECO 6.03 Increased By ▲ 0.26 (4.51%)
BML 52.61 Decreased By ▼ -0.39 (-0.74%)
BOP 34.23 Increased By ▲ 0.24 (0.71%)
CNERGY 8.16 Increased By ▲ 0.05 (0.62%)
DCL 12.23 Increased By ▲ 0.03 (0.25%)
FCCL 53.80 Increased By ▲ 0.97 (1.84%)
FCSC 5.24 Increased By ▲ 0.17 (3.35%)
FFL 18.03 Increased By ▲ 0.08 (0.45%)
FNEL 1.30 Increased By ▲ 0.01 (0.78%)
HUMNL 11.00 Increased By ▲ 0.12 (1.1%)
KEL 8.07 Increased By ▲ 0.05 (0.62%)
KOSM 5.39 Decreased By ▼ -0.13 (-2.36%)
MLCF 87.90 Increased By ▲ 1.39 (1.61%)
NBP 186.60 Increased By ▲ 1.44 (0.78%)
PACE 10.75 Increased By ▲ 0.17 (1.61%)
PAEL 39.95 Increased By ▲ 0.53 (1.34%)
PIAHCLA 26.19 Decreased By ▼ -0.03 (-0.11%)
PIBTL 17.32 Increased By ▲ 0.65 (3.9%)
PPL 233.49 Increased By ▲ 5.31 (2.33%)
PRL 34.98 Increased By ▲ 0.30 (0.87%)
PTC 67.71 Increased By ▲ 2.38 (3.64%)
SEARL 90.90 Increased By ▲ 0.77 (0.85%)
SSGC 27.20 Increased By ▲ 0.60 (2.26%)
TELE 8.57 Increased By ▲ 0.29 (3.5%)
THCCL 60.85 Increased By ▲ 2.35 (4.02%)
TPLP 8.78 Increased By ▲ 0.56 (6.81%)
TREET 24.65 Increased By ▲ 0.12 (0.49%)
TRG 71.50 Increased By ▲ 1.79 (2.57%)
WAVES 10.01 Increased By ▲ 0.07 (0.7%)
WTL 1.27 Decreased By ▼ -0.01 (-0.78%)
Topic

Covaxin vaccine

Bharat Biotech's COVID-19 shot 81pc effective

Bharat Biotech's COVID-19 shot 81pc effective

Published 03 Mar, 2021 07:16pm
  • COVAXIN demonstrates high clinical efficacy trend against COVID-19 but also significant immunogenicity against the rapidly emerging variants.
  • Only about 11% of the more than 10 million Indians vaccinated had taken the Bharat Biotech shot as of last week.
Indian state rejects Bharat Biotech vaccine approved without efficacy data

Indian state rejects Bharat Biotech vaccine approved without efficacy data

Updated 11 Feb, 2021 09:27pm
  • Bharat Biotech, which created COVAXIN with the state-run Indian Council of Medical Research, has said efficacy data from the late-stage clinical trial on nearly 26,000 volunteers will be out by next month.
  • There's an inhibition/concern among the community in general regarding the use of COVAXIN.
India to treat homegrown COVID-19 vaccine same as AstraZeneca's

India to treat homegrown COVID-19 vaccine same as AstraZeneca's

Published 14 Jan, 2021 05:18pm
  • No vaccine is a backup to the other - both vaccines are equally important, both vaccines are hugely immunogenic.
  • This achievement will indeed be hailed as a major Indian scientific achievement once efficacy data are released.
Brazilian clinics to buy India's COVAXIN vaccine pending approval

Brazilian clinics to buy India's COVAXIN vaccine pending approval

Published 13 Jan, 2021 08:24pm
  • Private sector talks to acquire Bharat's COVAXIN vaccine would not interfere with the Brazilian government's efforts to acquire vaccines for the public sector.
  • Bharat Biotech said on Tuesday that it had signed an agreement with a Brazil-based pharmaceutical seller, Precisa Medicamentos, to supply the vaccine even though it has yet to be approved.
India's Bharat Biotech to supply its COVID-19 vaccine to Brazil

India's Bharat Biotech to supply its COVID-19 vaccine to Brazil

Published 12 Jan, 2021 08:55pm
  • India's drug regulator has given emergency use approval to Bharat Biotech's COVAXIN, as well as to AstraZeneca and Oxford University's Covishield vaccine.
  • Bharat Biotech said it has signed an agreement with a Brazil-based pharmaceutical seller, Precisa Medicamentos, to supply COVAXIN.
Loading...